Heme oxygenase-1 activity is involved in the control of Toxoplasma gondii infection in the lung of BALB/c and C57BL/6 and in the small intestine of C57BL/6 mice

Veterinary Research

Volumn 44, Issue 1, 2013, Pages

  Araujo, Ester Cb ^a   Barbosa, Bellisa F ^a   Coutinho, Loyane B ^a   Barenco, Paulo Vc ^a   Sousa, Luciana A ^a   Milanezi, Cristiane M ^b   Bonfá, Giuliano ^b   Pavanelli, Wander R ^c   Silva, João S ^b   Ferro, Eloisa Av ^a   Silva, Deise Ao ^a   Cunha Junior, Jair P ^a   Silva, Neide M ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MUS; TOXOPLASMA GONDII;

CYTOKINE; HEME OXYGENASE 1; HEMIN; INDOLEAMINE 2,3 DIOXYGENASE; MESSENGER RNA; PROTOPORPHYRIN; PROTOPORPHYRIN ZINC;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LUNG; METABOLISM; MOUSE; PARASITOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SMALL INTESTINE; TOXOPLASMA; TOXOPLASMOSIS;

ANIMALS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HEMIN; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTESTINE, SMALL; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTOPORPHYRINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84885360599     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-44-89     Document Type: Article

References (64)

1. Congenital toxoplasmosis-prenatal aspects of Toxoplasma gondii infection. Rorman E, Zamir CS, Rilkis I, Bem-David H, Reprod Toxicol 2006 21 458 472
2. Toxoplasma gondii in animals used for human consumption. Tenter AM, Mem Inst Oswaldo Cruz 2009 104 364 369
3. Toxoplasma gondii: from animals to humans. Tenter AM, Heckeroth AR, Weiss LM, Int J Parasitol 2000 30 1217 1258
4. Neosporosis in animals-the last five years. Dubey JP, Schares G, Vet Parasitol 2011 180 90 108
5. Toxoplasmosis. Montoya JG, Liesenfeld O, Lancet 2004 363 1965 1976 (Pubitemid 38759657)
6. Toxoplasma gondii infection in humans and animals in the United States. Dubey JP, Jones JL, Int J Parasitol 2008 38 1257 1278
7. Toxoplasmosis. Remington JS, McLeod R, Thulliez P, Desmonts G, Infection diseases of the fetus and newborn infant Philadelphia: Saunders, Remington JS, Klein J, 5 2001 205 356
8. Immune response to Toxoplasma gondii. Filisetti D, Candolfi E, Ann Ist Super Sanita 2004 40 71 80 (Pubitemid 39310674)
9. Synergistic role of CD4§ssup§+§esup§ and CD8§ssup§+§esup§ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A, J Immunol 1991 146 286 292
10. Simultaneous depletion of CD4§ssup§+§esup§ and CD8§ssup§+§esup§ T lymphocytes is required to reactive chronic infection with Toxoplasma gondii. Gazzinelli RT, Hu Y, Hieny S, Cheever A, Sher A, J Immunol 1992 149 175 180
11. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4§ssup§ +§esup§ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R, Müller W, Trinchieri G, Sher A, J Immunol 1996 157 798 805 (Pubitemid 26231385)
12. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Neyer LE, Grunig G, Fort M, Remington JS, Rennick D, Hunter CA, Infect Immun 1997 65 1675 1682 (Pubitemid 27193585)
13. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, Fort M, Kang H, Gufwoli E, J Immunol 2000 164 5375 5382 (Pubitemid 30305218)
14. Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of AxB/BxA recombinant inbred and B10 congenic mice. McLeod R, Skamene E, Brown C, Eisenhauer PB, Mack D, Mack DG, J Immunol 1989 143 3031 3034 (Pubitemid 19281856)
15. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. McLeod R, Eisenhauer P, Mack D, Brown C, Filice G, Spitalny G, J Immunol 1989 142 3247 3255 (Pubitemid 19129950)
16. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii. Suzuki Y, Yang Q, Remington JS, J Parasitol 1995 81 1032 1034 (Pubitemid 26012373)
17. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. Brown CR, McLeod R, J Immunol 1990 145 3438 3441
18. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Suzuki Y, Joh K, Orellana MA, Conley FK, Remington JS, Immunology 1991 74 732 739
19. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice. Blackwell JM, Roberts CW, Alexander J, Parasite Immunol 1993 15 317 324 (Pubitemid 23202084)
20. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Brown CR, Hunter CA, Estes RG, Beckmann E, Forman J, David C, Remington JS, McLeod R, Immunology 1995 85 419 428
21. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Suzuki Y, Orellana MA, Schreiber RD, Remington JS, Science 1988 240 516 518
22. Interferon-γ restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immunity-related GTPases. Takács AC, Swierzy IJ, Lüder CGK, PLoS One 2012 7 45440
23. Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. Pfefferkorn ER, Rebhun S, Eckel M, J Interferon Res 1986 6 267 279 (Pubitemid 16039051)
24. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Silva NM, Rodrigues CV, Santoro MM, Reis LF, Alvarez-Leite JI, Gazzinelli RT, Infect Immun 2002 70 859 868 (Pubitemid 34083850)
25. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Fujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y, Wada H, Seishima M, Infect Immun 2002 70 779 786 (Pubitemid 34083840)
26. Microsomal heme oxygenase. Tenhunen R, Marver HS, Schmid R, J Biol Chem 1969 224 6388 6394
27. Heme oxygenase-1: from biology to therapeutic potential. Soares MP, Bach FH, Trends Mol Med 2009 15 50 58
28. Heme oxygenase: colors of defense against cellular stress. Otterbein LE, Choi AMK, Am J Physiol Lung Cell Mol Physiol 2000 279 1029 1037
29. Different faces of the heme-heme oxygenase system in inflammation. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG, Pharmacol Rev 2003 55 551 571 (Pubitemid 37013215)
30. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Ryter SW, Alam J, Choi AMK, Physiol Rev 2006 86 583 650
31. Immunoregulatory effects of HO-1: how does it work? Soares MP, Marguti I, Cunha A, Larsen R, Curr Opin Pharmacol 2009 9 482 489
32. Mechanisms of cell protection by heme oxygenase-1. Gozzelino R, Jeney V, Soares MP, Annu Rev Pharmacol Toxicol 2010 50 323 354
33. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM, Nat Med 2000 6 422 428 (Pubitemid 30208159)
34. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A, Am J Pathol 2004 165 1045 1053 (Pubitemid 39129309)
35. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. Zuckerbraun BS, Billiar TR, Otterbein SL, Kim PKM, Liu F, Choi AMK, Bach FH, Otterbein LE, J Exp Med 2003 198 1707 1716 (Pubitemid 37494163)
36. Heme-oxygenase-1 induction and carbon monoxide- releasing molecule inhibit lipopolysaccharide (LPS)-induced high-mobility group box 1 release in vitro and improve survival of mice in LPS- and cecal ligation and puncture- induced sepsis model in vivo. Tsoyi K, Lee TY, Lee YS, Kim HJ, Seo HG, Lee JH, Chang KC, Mol Pharmacol 2009 76 173 182
37. Anti-asthmatic effects of Angelica dahurica against ovalbumin-induced airway inflammation via upregulation of heme oxygenase-1. Lee MY, Seo CS, Lee JA, Lee NH, Kim JH, Ha H, Zheng MS, Son JK, Shin HK, Food Chem Toxicol 2011 49 829 837
38. Heme oxygenase-1 suppresses hepatitis C vírus replication and increases resistance of hepatocytes to oxidant injury. Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown KE, Luxon BA, Schmidt WN, Hepatology 2008 48 1430 1439
39. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, Chora A, Rodrigues CD, Gregoire IP, Cunha-Rodrigues M, Portugal S, Soares MP, Mota MM, Nat Med 2007 13 703 710 (Pubitemid 46889755)
40. Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine Plasmodium liver infection. Epiphanio S, Mikolajczak SA, Gonçalves LA, Pamplona A, Portugal S, Albuquerque S, Goldberg M, Rebelo S, Anderson DG, Akinc A, Vornlocher HP, Kappe SH, Soares MP, Mota MM, Cell Host Microbe 2008 3 331 338 (Pubitemid 351635999)
41. Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation. Pham NH, Mouriz J, Kima PE, Infect Immun 2005 73 8322 8233
42. Oxidative stress fuels Trypanosoma cruzi infection in mice. Paiva CN, Feijó DF, Dutra FF, Carneiro VC, Freitas GB, Alves LS, Mesquita J, Fortes GB, Figueiredo RT, Souza HS, Fantappié MR, Lannes-Vieira J, Bozza MT, J Clin Invest 2012 122 2531 2542
43. Role of cytokines and major histocompatibility complex restriction in mouse resistance to infection with a natural recombinant strain (type I-III) of Toxoplasma gondii. Fux B, Rodrigues CV, Portela RW, Silva NM, Su C, Sibley D, Vitor RW, Gazzinelli RT, Infect Immun 2003 71 6392 6401 (Pubitemid 37337698)
44. CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system. Benevides L, Milanezi CM, Yamauchi LM, Benjamim CF, Silva JS, Silva NM, Am J Pathol 2008 173 741 751
45. The impaired pregnancy outcome in murine congenital toxoplasmosis is associated with a pro-inflammatory immune response, but not correlated with decidual inducible nitric oxide synthase expression. Coutinho LB, Gomes AO, Araújo EC, Barenco PV, Santos JL, Caixeta DR, Silva DA, Cunha-Júnior JP, Ferro EA, Silva NM, Int J Parasitol 2012 42 341 352
46. Long-term passage of tachyzoites in tissue culture can attenuate virulence of Neospora caninum in vivo. Bartley PM, Wright S, Sales J, Chianini F, Buxton D, Innes EA, Parasitology 2006 135 421 432 (Pubitemid 44605834)
47. Toxoplasma gondii: the severity of toxoplasmic encephalitis in C57BL/6 mice is associated with increased ALCAM and VCAM-1 expression in the central nervous system and higher blood-brain barrier permeability. Silva NM, Manzan RM, Carneiro WP, Milanezi CM, Silva JS, Ferro EA, Mineo JR, Exp Parasitol 2010 126 167 177
48. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Bradford MM, Anal Biochem 1976 72 248 254
49. Cysteine protease inhibitors block Toxoplasma gondii microneme secretion and cell invasion. Teo CF, Zhou XW, Bogyo M, Carruthers VB, Antimicrob Agents Chemother 2007 51 679 688 (Pubitemid 46185290)
50. Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection. Luz NF, Andrade BB, Feijó DF, Araújo-Santos T, Carvalho GQ, Andrade D, Abánades DR, Melo EV, Silva AM, Brodskyn CI, Barral-Netto M, Barral A, Soares RP, Almeida RP, Bozza MT, Borges VM, J Immunol 2012 188 4460 4467
51. Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Seixas E, Gozzelino R, Chora A, Ferreira A, Silva G, Larsen R, Rebelo S, Penido C, Smith NR, Coutinho A, Soares MP, Proc Natl Acad Sci USA 2009 106 15837 15842
52. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, Colonna M, Sibley LD, Immunity 2008 29 306 317
53. Heme oxygenase-1: unleashing the protective properties of heme. Otterbein LE, Soares MP, Yamashita K, Bach FH, Trends Immunol 2003 24 449 455 (Pubitemid 36928103)
54. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice. Wagner A, Förster-Waldl E, Garner-Spitzer E, Schabussova I, Kundi M, Pollak A, Scheiner O, Joachim A, Wiedermann U, Int J Parasitol 2009 39 465 472
55. Partial depletion of CD4(§ssup§+§esup§) CD25(§ssup§+§esup§)Foxp3(§ssup§+§esup§) T regulatory cells significantly increases morbidity during acute phase Toxoplasma gondii infection in resistant BALB/c mice. Morampudi V, De Craeye S, Le Moine A, Detienne S, Braun MY, D'Souza S, Microbes Infect 2011 13 394 404
56. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Khan IA, Matsuura T, Kasper LH, Parasite Immunol 1995 17 185 195
57. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. Yamashita K, Ollinger R, McDaid J, Sakahama H, Wang H, Tyagi S, Csizmadia E, Smith NR, Soares MP, Bach FH, FASEB J 2006 20 776 778 (Pubitemid 46671212)
58. Induction of indoleamine 2,3-dioxygenase expression via heme oxygenase-1-dependant pathway during murine dendritic cell maturation. Jung ID, Lee JS, Lee CM, Noh KT, Jeong YI, Park WS, Chun SH, Jeong SK, Park JW, Son KH, Heo DR, Lee MG, Shin YK, Kim HW, Yun CH, Park YM, Biochem Pharmacol 2010 80 491 505
59. Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK/STAT pathway. Cerávolo IP, Chaves AC, Bonjardim CA, Sibley D, Romanha AJ, Gazzinelli RT, Infect Immun 1999 67 2233 2240 (Pubitemid 29200477)
60. IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-gamma. Chaves AC, Cerávolo IP, Gomes JA, Zani CL, Romanha AJ, Gazzinelli RT, Eur J Immunol 2001 31 333 344 (Pubitemid 32166586)
61. Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. Divanovic S, Sawtell NM, Trompette A, Warning JI, Dias A, Cooper AM, Yap GS, Arditi M, Shimada K, Duhadaway JB, Prendergast GC, Basaraba RJ, Mellor AL, Munn DH, Aliberti J, Karp CL, J Infect Dis 2012 205 152 161
62. Zinc protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Maines MD, Biochim Biophys Acta 1981 673 339 350
63. Indoleamine 2,3-dioxygenase in intestinal immunity and inflammation. Cherayil BJ, Inflamm Bowel Dis 2009 15 1391 1396
64. Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis. Harrington L, Srikanth CV, Antony R, Rhee SJ, Mellor AL, Shi HN, Cherayil BJ, Infect Immun 2008 76 3045 3053